KR100338916B1 - 피롤리디닐 하이드록삼산 화합물의 제조방법 - Google Patents
피롤리디닐 하이드록삼산 화합물의 제조방법 Download PDFInfo
- Publication number
- KR100338916B1 KR100338916B1 KR1019990026361A KR19990026361A KR100338916B1 KR 100338916 B1 KR100338916 B1 KR 100338916B1 KR 1019990026361 A KR1019990026361 A KR 1019990026361A KR 19990026361 A KR19990026361 A KR 19990026361A KR 100338916 B1 KR100338916 B1 KR 100338916B1
- Authority
- KR
- South Korea
- Prior art keywords
- hydroxy
- phenyl
- acetamide
- added
- compound
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D207/08—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon radicals, substituted by hetero atoms, attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D207/10—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D207/12—Oxygen or sulfur atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P23/00—Anaesthetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/10—Antioedematous agents; Diuretics
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Diabetes (AREA)
- Pain & Pain Management (AREA)
- Hematology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Rheumatology (AREA)
- Anesthesiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyrrole Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US9763398P | 1998-08-24 | 1998-08-24 | |
| US60/097,633 | 1998-08-24 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| KR20000016898A KR20000016898A (ko) | 2000-03-25 |
| KR100338916B1 true KR100338916B1 (ko) | 2002-05-30 |
Family
ID=22264376
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| KR1019990026361A Expired - Fee Related KR100338916B1 (ko) | 1998-08-24 | 1999-07-01 | 피롤리디닐 하이드록삼산 화합물의 제조방법 |
Country Status (18)
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2002088082A2 (en) * | 2001-04-30 | 2002-11-07 | Pfizer Products Inc. | Process for preparing hydroxypyrrolidinyl ethylamine compounds useful as kappa agonists |
| AU2003269399A1 (en) * | 2002-11-01 | 2004-05-25 | Pfizer Products Inc. | Process for the preparation of pyrrolidinyl ethylamine compounds via a copper-mediated aryl amination |
| US7744750B2 (en) * | 2005-11-17 | 2010-06-29 | Exxonmobil Chemical Patents Inc. | Process for reducing Bromine Index of hydrocarbon feedstocks |
| US8057664B2 (en) * | 2005-11-17 | 2011-11-15 | Exxonmobil Chemical Patents, Inc. | Process for reducing bromine index of hydrocarbon feedstocks |
| US7517824B2 (en) * | 2005-12-06 | 2009-04-14 | Exxonmobil Chemical Company | Process for steam stripping hydrocarbons from a bromine index reduction catalyst |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB8618188D0 (en) * | 1986-07-25 | 1986-09-03 | Ici Plc | Diamine compounds |
| CA1336333C (en) * | 1988-05-20 | 1995-07-18 | Davide Della Bella | Pyrrolidone-2 compounds and their use for central analgesic activity |
| DE4034785A1 (de) * | 1990-11-02 | 1992-05-07 | Merck Patent Gmbh | 1-(2-arylethyl)-pyrrolidine |
| KR0132001B1 (ko) * | 1994-05-21 | 1998-04-17 | 강박광 | 신규한 치환된 이미다졸 유도체 |
| IL117440A0 (en) * | 1995-03-31 | 1996-07-23 | Pfizer | Pyrrolidinyl hydroxamic acid compounds and their production process |
| MX9701042A (es) * | 1996-02-07 | 1998-05-31 | Pfizer | Compuestos del acido hidroxamico. |
| TNSN97092A1 (ar) * | 1996-09-18 | 1999-12-31 | Agouron Pharma | مثبطات انزيم بروتيني فلزي وتركيبات صيدلانية تحتوي على تلك المثبتطات واستخدامها الصيدلاني وطرق ومركبات وسيطة مفيدة لتحضير التركيبات المذكورة. |
-
1999
- 1999-06-10 IL IL13042999A patent/IL130429A0/xx unknown
- 1999-06-10 EP EP99304531A patent/EP0982297A3/en not_active Withdrawn
- 1999-06-11 HU HU9901944A patent/HUP9901944A3/hu unknown
- 1999-06-15 RU RU99113363/04A patent/RU2163235C1/ru not_active IP Right Cessation
- 1999-06-17 IN IN883DE1999 patent/IN190844B/en unknown
- 1999-06-17 AR ARP990102917A patent/AR016500A1/es not_active Application Discontinuation
- 1999-06-29 JP JP18308699A patent/JP3245578B2/ja not_active Expired - Fee Related
- 1999-06-30 CA CA002277242A patent/CA2277242A1/en not_active Abandoned
- 1999-06-30 ZA ZA9904285A patent/ZA994285B/xx unknown
- 1999-07-01 BR BR9902525-6A patent/BR9902525A/pt not_active IP Right Cessation
- 1999-07-01 PL PL99334144A patent/PL334144A1/xx unknown
- 1999-07-01 ID IDP990637D patent/ID23462A/id unknown
- 1999-07-01 YU YU31499A patent/YU31499A/sh unknown
- 1999-07-01 CN CN99108932A patent/CN1245799A/zh active Pending
- 1999-07-01 KR KR1019990026361A patent/KR100338916B1/ko not_active Expired - Fee Related
- 1999-07-02 TR TR1999/01546A patent/TR199901546A2/xx unknown
- 1999-08-16 US US09/374,869 patent/US6031114A/en not_active Expired - Fee Related
- 1999-08-23 AU AU44665/99A patent/AU4466599A/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| CA2277242A1 (en) | 2000-02-24 |
| HUP9901944A2 (hu) | 2000-06-28 |
| JP3245578B2 (ja) | 2002-01-15 |
| YU31499A (sh) | 2002-11-15 |
| HUP9901944A3 (en) | 2001-10-29 |
| IL130429A0 (en) | 2000-06-01 |
| PL334144A1 (en) | 2000-02-28 |
| ZA994285B (en) | 2001-01-02 |
| IN190844B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) | 2003-08-23 |
| TR199901546A3 (tr) | 2000-04-21 |
| HU9901944D0 (en) | 1999-08-30 |
| EP0982297A2 (en) | 2000-03-01 |
| US6031114A (en) | 2000-02-29 |
| CN1245799A (zh) | 2000-03-01 |
| AR016500A1 (es) | 2001-07-04 |
| BR9902525A (pt) | 2000-05-02 |
| EP0982297A3 (en) | 2001-08-01 |
| KR20000016898A (ko) | 2000-03-25 |
| AU4466599A (en) | 2000-03-09 |
| RU2163235C1 (ru) | 2001-02-20 |
| JP2000072744A (ja) | 2000-03-07 |
| TR199901546A2 (xx) | 2000-04-21 |
| ID23462A (id) | 2000-04-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Fleet et al. | Synthesis from D-mannose of 1, 4-dideoxy-1, 4-imino-L-ribitol and of the α-mannosidase inhibitor 1, 4-dideoxy-1, 4-imino-D-talitol | |
| SK126893A3 (en) | Derivatives of perhydroisoindole and preparation thereof | |
| EP0374801A2 (en) | Novel N-sustituted azaheterocyclic carboxylic acids | |
| JP3035356B2 (ja) | ピロリジニルヒドロキサム酸化合物及びその製造方法 | |
| EP0340064A1 (fr) | Benzodiazépines, leur procédé et intermédiaires de préparation et leurs applications en thérapeutique | |
| KR100420423B1 (ko) | 아릴 축합된 아자 다환식 화합물 | |
| NZ228721A (en) | Substituted indoles and indazoles and pharmaceutical compositions | |
| KR100338916B1 (ko) | 피롤리디닐 하이드록삼산 화합물의 제조방법 | |
| EP1341783A1 (en) | Isoquinoline derivatives useful in the treatment of cns disorders | |
| US20060052613A1 (en) | 1-alkyl-3-aminoindazoles | |
| Maison et al. | Synthesis of novel pipecolic acid derivatives: a multicomponent approach from 3, 4, 5, 6-tetrahydropyridines | |
| Chen et al. | An efficient synthesis of the indole acetic acid metabolite of MK-0462 | |
| AU718434B2 (en) | Process for producing indoline compounds and intermediates for the production of the same | |
| US20070135508A1 (en) | 3,6-Disubstituted azabicyclo hexane derivatives as muscarinic receptor antagonists | |
| BG99253A (en) | Epi - epibatydine derivatives | |
| KR20010042750A (ko) | 거울상 이성질체-유리ｎ-메틸-ｎ-[(1ｓ)-1-페닐-2-((3ｓ)-3-히드록시피롤리딘-1-일)에틸]-2,2-디페닐아세트아미드의 제조 방법 | |
| RU2291862C2 (ru) | Способ получения арилконденсированных полициклических лактамов | |
| JP4574944B2 (ja) | ジスタマイシン誘導体の調製方法 | |
| JPS6317860A (ja) | 化合物 | |
| JP2004507524A (ja) | ３−アミノメチル−４−ｚ−メトキシイミノピロリジンの新規な製造方法 | |
| US4840950A (en) | 4-arylcarbonyl-1-[(4-morpholinyl)-lower-alkyl]-1H-indoles | |
| MXPA99006264A (en) | Procedure for pirrolidinyl hydroxam acid compounds | |
| KR100469030B1 (ko) | 시사프라이드의 합성방법 | |
| US4874761A (en) | 4-arylcarbonyl-1-[(4-morpholinyl)-lower-alkyl]-1H-indoles | |
| HK1025966A (en) | Process for pyrrolidinyl hydroxamic acid compounds |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A201 | Request for examination | ||
| PA0109 | Patent application |
St.27 status event code: A-0-1-A10-A12-nap-PA0109 |
|
| PA0201 | Request for examination |
St.27 status event code: A-1-2-D10-D11-exm-PA0201 |
|
| PG1501 | Laying open of application |
St.27 status event code: A-1-1-Q10-Q12-nap-PG1501 |
|
| E902 | Notification of reason for refusal | ||
| PE0902 | Notice of grounds for rejection |
St.27 status event code: A-1-2-D10-D21-exm-PE0902 |
|
| T11-X000 | Administrative time limit extension requested |
St.27 status event code: U-3-3-T10-T11-oth-X000 |
|
| T11-X000 | Administrative time limit extension requested |
St.27 status event code: U-3-3-T10-T11-oth-X000 |
|
| E13-X000 | Pre-grant limitation requested |
St.27 status event code: A-2-3-E10-E13-lim-X000 |
|
| P11-X000 | Amendment of application requested |
St.27 status event code: A-2-2-P10-P11-nap-X000 |
|
| P13-X000 | Application amended |
St.27 status event code: A-2-2-P10-P13-nap-X000 |
|
| E701 | Decision to grant or registration of patent right | ||
| PE0701 | Decision of registration |
St.27 status event code: A-1-2-D10-D22-exm-PE0701 |
|
| GRNT | Written decision to grant | ||
| PR0701 | Registration of establishment |
St.27 status event code: A-2-4-F10-F11-exm-PR0701 |
|
| PR1002 | Payment of registration fee |
St.27 status event code: A-2-2-U10-U11-oth-PR1002 Fee payment year number: 1 |
|
| PG1601 | Publication of registration |
St.27 status event code: A-4-4-Q10-Q13-nap-PG1601 |
|
| LAPS | Lapse due to unpaid annual fee | ||
| PC1903 | Unpaid annual fee |
St.27 status event code: A-4-4-U10-U13-oth-PC1903 Not in force date: 20050521 Payment event data comment text: Termination Category : DEFAULT_OF_REGISTRATION_FEE |
|
| PC1903 | Unpaid annual fee |
St.27 status event code: N-4-6-H10-H13-oth-PC1903 Ip right cessation event data comment text: Termination Category : DEFAULT_OF_REGISTRATION_FEE Not in force date: 20050521 |